| Market Cap | 513M 443M 416M 379M 713M 48.71B 717M 4.92B 1.92B 24.78B 1.93B 1.89B 82.15B | P/E 2017 |
-17.4x | P/E 2018 | -41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 460M 397M 373M 340M 640M 43.67B 643M 4.41B 1.72B 22.21B 1.73B 1.69B 73.66B | EV / Sales 2017 |
53,919,197x | EV / Sales 2018 | 19,487,976x |
| Free-Float |
80.58% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.86% | - | - | 352M | |
| +0.58% | +1.36% | -14.52% | -7.11% | 13.45B | |
| +0.50% | -0.99% | -33.45% | -56.57% | 4.9B | |
| 0.00% | -2.66% | -8.18% | -5.18% | 4.52B | |
| +0.69% | -0.31% | -4.12% | -30.38% | 3.99B | |
| +0.22% | +0.11% | -20.89% | +2.12% | 3.57B | |
| -1.08% | +2.65% | -0.54% | -2.29% | 3.51B | |
| +0.54% | +0.07% | -10.60% | +5.50% | 3.28B | |
| +0.87% | -1.70% | -24.37% | -13.70% | 2.36B | |
| +0.99% | +1.24% | -26.89% | -15.39% | 1.72B | |
| Average | +0.33% | -0.56% | -15.95% | -13.67% | 4.59B | |
| Weighted average by Cap. | +0.37% | -0.28% | -15.20% | -13.53% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 3.08 2.66 2.5 2.28 4.28 292.12 4.3 29.53 11.49 148.59 11.56 11.31 492.71 | 18.69 16.12 15.17 13.82 25.98 1.77K 26.13 179.31 69.79 902.44 70.18 68.66 2.99K |
| Net income | -8.89M -7.67M -7.21M -6.57M -12.36M -844M -12.43M -85.29M -33.2M -429M -33.38M -32.66M -1.42B | -8.41M -7.26M -6.83M -6.22M -11.7M -799M -11.76M -80.71M -31.41M -406M -31.59M -30.91M -1.35B |
| Net Debt | -1.84M -1.59M -1.49M -1.36M -2.56M -175M -2.57M -17.64M -6.87M -88.77M -6.9M -6.75M -294M | -53.08M -45.78M -43.07M -39.23M -73.78M -5.04B -74.18M -509M -198M -2.56B -199M -195M -8.5B |
Employees
-
Sector
Pharmaceuticals
